Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

64Cu-DOTA-trastuzumab Positron Emission Tomography in Patients With Gastric Cancer

NCT01939275 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01939275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
64Cu-DOTA-trastuzumab Positron Emission Tomography in Patients With Gastric Cancer
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 19, 2014
Completion date
August 5, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the gastroesophageal junction, diffuse adenocarcinoma of the stomach, intestinal adenocarcinoma of the stomach, mixed adenocarcinoma of the stomach, recurrent gastric cancer, stage ia gastric cancer, stage ib gastric cancer, stage iia gastric cancer, stage iib gastric cancer, stage iiia gastric cancer, stage iiib gastric cancer, stage iiic gastric cancer, stage iv gastric cancer